2025年全球克隆與誘變市場報告

近年來，克隆和誘變市場規模迅速擴張，從2024年的29.8億美元成長到2025年的35.4億美元，複合年成長率為18.7%。預測期內的成長可歸因於基因研究的進步、藥物研究需求的不斷成長、農業領域基因工程的興起、生物醫學研究應用以及分子生物學領域的開創性應用。

預計未來幾年克隆與誘變市場將快速成長，到2029年將達到71.3億美元，年複合成長率（CAGR）為19.2%。預測期內的成長可歸因於基因治療應用的不斷擴展、個性化醫療需求的不斷成長、功能基因組學的進步、合成生物學的創新以及農業生物技術的應用。預測期內的主要趨勢包括治療中的標靶基因編輯、更高的精準度和特異性、可自訂的分子工具、農業應用的不斷擴展以及倫理和監管考慮。

克隆和誘變是分子生物學中的重要技術，涉及複製多個相同的DNA片段、基因或整個基因組，以及在DNA序列中引入突變。這些技術在研究基因功能和調控、開發新藥和新療法以及生產重組酶和蛋白質方面發揮著重要作用。

與克隆和誘變相關的關鍵產品包括克隆試劑套件、誘變試劑套件和其他相關工具。克隆試劑套件是專門設計的實驗室儀器，旨在簡化將特定DNA片段或基因克隆到克隆載體的過程。這些套件對於各種克隆實驗至關重要，包括基因克隆、亞克隆、特異性突變和文庫構建。平端克隆、拓樸PCR克隆、無縫克隆和特異性誘變等技術被學術和研究機構、生物技術公司以及其他營業單位分子生物學研究的實體所採用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 最新報告系列的一部分，該系列提供了克隆和誘變軟體市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的克隆和誘變軟體市場佔有率、詳細的克隆和誘變軟體細分市場、市場趨勢和商業機會，以及您在克隆和誘變軟體行業取得成功所需的數據。本克隆和誘變軟體市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

我們預測未來五年該市場將成長19.2%，較先前預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會透過對來自芬蘭和比利時等關鍵地區的限制性酵素和特異性誘變試劑套件徵收關稅直接影響美國，從而減緩生物技術研究的進展並增加分子生物學實驗的成本。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

受基因改造產品需求成長的推動，克隆和誘變市場預計將成長。基因改造產品包括經過精心設計的基因操作以引入新性狀或特性的生物、材料和物質。克隆是一種創建精確基因拷貝的科學過程，具有多種應用，包括培育抗性昆蟲和植物品種，以及促進醫學中的基因治療。根據德國生物技術和製藥公司拜耳股份公司的年度報告，基因改造產品的銷售額正在大幅成長，作物科學部門的銷售額將從 2021 年的 223.1479 億美元增至 2022 年的 277.9438 億美元。對基因改造產品日益成長的需求是克隆和誘變市場的主要驅動力。這些數據是根據拜耳股份公司 2023 年 2 月發布的年度報告中提供的資訊。

由於對個人化醫療的需求不斷成長，克隆和誘變市場預計將成長。個人化醫療是一種創新的醫療保健方法，可根據每位患者的個人特徵量身訂做治療和介入措施。克隆和誘變在個人化醫療的各個方面發揮關鍵作用，包括疾病建模、藥物開發、標靶識別、基因治療、生物標記發現、患者特異性細胞治療、藥物基因組學和個人化治療的基因組編輯。 2022 年 4 月，個人化醫療聯盟報告稱，美國食品藥物管理局(FDA) 藥品評估和研究中心 (CDER) 在 2022 年核准了37 個新分子實體 (NME)。在治療性 NME 中，約 34%（其中 12 個）被個人化醫療聯盟 (PMC) 歸類為個人化醫療。對個人化醫療的這種不斷成長的需求是推動克隆和誘變市場成長的主要因素。

克隆和誘變市場的主要企業正在利用噬菌體基因組改造技術等先進技術來提升其競爭地位。噬菌體基因組改造技術旨在有意改變噬菌體（一種感染細菌的病毒）的遺傳物質，用於研究、治療和工業應用。例如，韓國生物技術公司 iNtRON BIoTechnology 於 2022 年 10 月推出了其第二代機器人噬菌體技術。此技術利用隨機轉座子誘變技術來改造噬菌體的基因組，從而識別和去除非必需基因。 iNtRON 旨在設計和生產具有特定特性的噬菌體，以促進免疫療法和抗病毒解決方案的開發。

為了保持競爭力，克隆和誘變市場的主要企業也積極探索聚合酵素鏈鎖反應(PCR) 等創新技術。 PCR 是一種擴增特定 DNA 片段的分子生物學實驗室技術。美國生技公司 Bio-Rad Laboratories 於 2023 年 4 月推出了 ID-Check 物種形成解決方案。這種即時PCR方法有助於肉類物種識別，能夠識別食品、飼料和環境樣本中的動物類型。它提供了一種可靠、快速的原料來源驗證方法，並增強了生產線清潔流程。此解決方案以高靈敏度檢測各種肉類物種的粒線體 DNA，可檢測濃度低至 0.001% 的 DNA。它採用雙重檢測系統，確保準確性和便利性。

2022年5月，QIAGEN NV（荷蘭）收購了BLIRT SA。此次收購旨在增強QIAGEN在創新分子診斷和生物製藥解決方案開發方面的能力。 BLIRT是一家總部位於波蘭的製造商，專門生產用於分子克隆和定點特異性的重組酶。

克隆與誘變市場的主要企業包括賽默飛世爾科技、Takara Bio Inc.、安捷倫科技公司、Jena Bioscience GmbH、Transgen Biotech Co、New England Biolabs、默克公司、Promega Corporation、Bio-Rad Laboratories Inc.、丹納赫、Genomax Technologies Pte Ltd、GENEWIZx、abmak Inc. Sciences、Bio-Techne、Charles River Laboratories、Integrated DNA Technologies、MedGenome、Sino Biological Inc.、BioChain Institute Inc.、OriGene Technologies Inc.、Creative Biogene、Bioneer Corporation、Synbio Technologies LLC、Lucigen Corporation、Biomatik Corporation、Quanta BioDesign Ltd. 和 Inscripta Inc.。

2024年克隆和誘變市場最大的地區是北美。預計在預測期內，亞太地區將成為全球克隆和誘變市場報告中所預測成長最快的地區。克隆和誘變市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。

克隆和誘變市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

克隆和誘變市場包括營業單位透過檢測試劑套件、生物素-PEG連接體、比勒蛋白和細胞產生的收益。市場規模包括服務供應商銷售或包含在其服務產品中的相關產品的價值。克隆和誘變市場也包括DNA分離、克隆載體和DNA連接酶等技術的銷售。此市場的價值是指「工廠門口」價值，即產品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球克隆與誘變：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球克隆與誘變市場：成長率分析
• 全球克隆與誘變市場表現：規模與成長，2019-2024
• 全球克隆與誘變市場預測：規模與成長，2024-2029 年，2034 年
• 全球克隆與誘變：總目標市場（TAM）

第6章 市場細分

• 全球克隆和誘變市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 克隆試劑套件
• 誘變試劑套件
• 其他
• 全球克隆和誘變市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 平端克隆
• Topo-PCR克隆
• 無縫克隆
• 定點突變
• 其他
• 全球克隆和誘變市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
• 學術研究機構
• 生技公司
• 其他
• 全球克隆和誘變市場：克隆試劑套件細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 細菌克隆試劑套件
• 酵母克隆試劑套件
• 病毒克隆試劑套件
• 質體克隆試劑套件
• 全球克隆和誘變市場：誘變試劑套件細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 定點突變套件
• 隨機誘變試劑套件
• 易錯PCR試劑套件
• CRISPR 或 Cas9 誘變試劑套件
• 全球克隆與誘變市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
• 酵素
• 向量系統
• 配件

第7章 區域和國家分析

• 全球克隆與誘變市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 全球克隆與誘變市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 克隆與誘變市場：競爭格局
• 克隆和誘變市場：公司簡介
  • Thermo Fisher Scientific
  • Takara Bio Inc.
  • Agilent Technologies Inc.
  • Jena Bioscience GmbH
  • Transgen BIoTech Co

第31章：其他領先和創新企業

• New England Biolabs
• Merck KGaA
• Promega Corporation
• Bio-Rad Laboratories Inc.
• Danaher
• Genomax Technologies Pte Ltd
• GENEWIZ Inc.
• abm Inc.
• GenScript
• EZBioscience
• Codex DNA Inc.
• Aragen Life Sciences
• Bio-Techne
• Charles River Laboratories
• Integrated DNA Technologies

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

• 2029 年克隆與誘變市場：提供新機會的國家
• 2029 年克隆與誘變市場：細分領域帶來新機會
• 2029 年克隆與誘變市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.

The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cloning and mutagenesis software market research report is one of a series of new reports from The Business Research Company that provides cloning and mutagenesis software market statistics, including cloning and mutagenesis software industry global market size, regional shares, competitors with a cloning and mutagenesis software market share, detailed cloning and mutagenesis software market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis software industry. This cloning and mutagenesis software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cloning and mutagenesis market size has grown rapidly in recent years. It will grow from $2.98 billion in 2024 to $3.54 billion in 2025 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to advancements in genetic research, increasing demand in pharmaceutical research, rise of genetic engineering in agriculture, biomedical research applications, pioneer applications in molecular biology.

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $7.13 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to expanding applications in gene therapy, rising demand for personalized medicine, advancements in functional genomics, innovations in synthetic biology, application in agricultural biotechnology. Major trends in the forecast period include targeted gene editing in therapeutics, enhanced precision and specificity, customizable molecular tools, expanded applications in agriculture, ethical and regulatory considerations.

The forecast of 19.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on restriction enzymes and site-directed mutagenesis kits, sourced from key regions such as Finland and Belgium, which could lead to slowed biotech research progress and higher molecular biology experiment costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The cloning and mutagenesis market is expected to experience growth driven by the rising demand for genetically modified products. Genetically modified products involve organisms, materials, or substances that undergo deliberate genetic engineering to introduce new traits or characteristics. Cloning, a scientific process for producing exact genetic copies, is utilized in various applications, including creating insect and plant-resistant species and facilitating gene therapy in medical sciences. An annual report from Bayar AG, a Germany-based biotechnology and pharmaceutical company, revealed significant growth in the sales of genetically modified products, with the crop sciences segment reaching $27,794.38 million in 2022, up from $22,314.79 million in 2021. This increased demand for genetically modified products is a key driver of the cloning and mutagenesis market. The data is based on information provided in the annual report published by Bayar AG in February 2023.

The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. In April 2022, the Personalized Medicine Coalition reported that the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Among the therapeutic NMEs, approximately 34% (12 of them) were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.

Major players in the cloning and mutagenesis market are leveraging advanced technologies, such as bacteriophage genome modifying technologies, to enhance their competitive position. Bacteriophage genome modifying technologies involve intentional alterations to the genetic material of bacteriophages, viruses that infect bacteria, for applications in research, therapy, or industry. An example is iNtRON Biotechnology, a South Korea-based biotech company, which introduced its 2nd generation Robot Bacteriophage technology in October 2022. This technology utilizes random transposon mutagenesis to modify the bacteriophage genome, enabling the identification and removal of non-essential genes. iNtRON aims to design and produce bacteriophages with specific characteristics, facilitating the development of immunotherapeutic agents and antiviral solutions.

Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.

In May 2022, QIAGEN N.V., a Netherlands-based provider of sample and assay technologies, acquired BLIRT SA for an undisclosed amount. This acquisition is intended to bolster QIAGEN's capabilities in developing innovative molecular diagnostics and biopharmaceutical solutions. BLIRT SA, a manufacturer based in Poland, specializes in recombinant enzymes used for molecular cloning and site-directed mutagenesis.

Major companies operating in the cloning and mutagenesis market include Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.

North America was the largest region in the cloning and mutagenesis market in 2024. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cloning And Mutagenesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cloning and mutagenesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cloning and mutagenesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cloning and mutagenesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Cloning Kits; Mutagenesis Kits; Other Product
• 2) By Technique: Blunt End Cloning; Topo PCR Cloning; Seamless Cloning; Site-Directed Mutagenesis; Other Techniques
• 3) By End User: Academic and Research Institutes; Biotechnology Companies; Other End User
• Subsegments:
• 1) By Cloning Kits: Bacterial Cloning Kits; Yeast Cloning Kits; Viral Cloning Kits; Plasmid Cloning Kits
• 2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits; Random Mutagenesis Kits; Error-Prone PCR Kits; CRISPR Or Cas9 Mutagenesis Kits
• 3) By Other Products: Enzymes; Vector Systems; Accessories
• Companies Mentioned: Thermo Fisher Scientific; Takara Bio Inc.; Agilent Technologies Inc.; Jena Bioscience GmbH; Transgen Biotech Co; New England Biolabs; Merck KGaA; Promega Corporation; Bio-Rad Laboratories Inc.; Danaher; Genomax Technologies Pte Ltd; GENEWIZ Inc.; abm Inc.; GenScript; EZBioscience; Codex DNA Inc.; Aragen Life Sciences; Bio-Techne; Charles River Laboratories; Integrated DNA Technologies; MedGenome; Sino Biological Inc.; BioChain Institute Inc.; OriGene Technologies Inc.; Creative Biogene; Bioneer Corporation; Synbio Technologies LLC; Lucigen Corporation; Biomatik Corporation; Quanta BioDesign Ltd.; Inscripta Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cloning And Mutagenesis Market Characteristics

3. Cloning And Mutagenesis Market Trends And Strategies

4. Cloning And Mutagenesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cloning And Mutagenesis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cloning And Mutagenesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cloning And Mutagenesis Market Growth Rate Analysis
• 5.4. Global Cloning And Mutagenesis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cloning And Mutagenesis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cloning And Mutagenesis Total Addressable Market (TAM)

6. Cloning And Mutagenesis Market Segmentation

• 6.1. Global Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloning Kits
• Mutagenesis Kits
• Other Product
• 6.2. Global Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blunt End Cloning
• Topo PCR Cloning
• Seamless Cloning
• Site-Directed Mutagenesis
• Other Techniques
• 6.3. Global Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic and Research Institutes
• Biotechnology Companies
• Other End User
• 6.4. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Cloning Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Cloning Kits
• Yeast Cloning Kits
• Viral Cloning Kits
• Plasmid Cloning Kits
• 6.5. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Mutagenesis Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site-Directed Mutagenesis Kits
• Random Mutagenesis Kits
• Error-Prone PCR Kits
• CRISPR Or Cas9 Mutagenesis Kits
• 6.6. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Vector Systems
• Accessories

7. Cloning And Mutagenesis Market Regional And Country Analysis

• 7.1. Global Cloning And Mutagenesis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cloning And Mutagenesis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cloning And Mutagenesis Market

• 8.1. Asia-Pacific Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cloning And Mutagenesis Market

• 9.1. China Cloning And Mutagenesis Market Overview
• 9.2. China Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cloning And Mutagenesis Market

• 10.1. India Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cloning And Mutagenesis Market

• 11.1. Japan Cloning And Mutagenesis Market Overview
• 11.2. Japan Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cloning And Mutagenesis Market

• 12.1. Australia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cloning And Mutagenesis Market

• 13.1. Indonesia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cloning And Mutagenesis Market

• 14.1. South Korea Cloning And Mutagenesis Market Overview
• 14.2. South Korea Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cloning And Mutagenesis Market

• 15.1. Western Europe Cloning And Mutagenesis Market Overview
• 15.2. Western Europe Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cloning And Mutagenesis Market

• 16.1. UK Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cloning And Mutagenesis Market

• 17.1. Germany Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cloning And Mutagenesis Market

• 18.1. France Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cloning And Mutagenesis Market

• 19.1. Italy Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cloning And Mutagenesis Market

• 20.1. Spain Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cloning And Mutagenesis Market

• 21.1. Eastern Europe Cloning And Mutagenesis Market Overview
• 21.2. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cloning And Mutagenesis Market

• 22.1. Russia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cloning And Mutagenesis Market

• 23.1. North America Cloning And Mutagenesis Market Overview
• 23.2. North America Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cloning And Mutagenesis Market

• 24.1. USA Cloning And Mutagenesis Market Overview
• 24.2. USA Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cloning And Mutagenesis Market

• 25.1. Canada Cloning And Mutagenesis Market Overview
• 25.2. Canada Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cloning And Mutagenesis Market

• 26.1. South America Cloning And Mutagenesis Market Overview
• 26.2. South America Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cloning And Mutagenesis Market

• 27.1. Brazil Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cloning And Mutagenesis Market

• 28.1. Middle East Cloning And Mutagenesis Market Overview
• 28.2. Middle East Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cloning And Mutagenesis Market

• 29.1. Africa Cloning And Mutagenesis Market Overview
• 29.2. Africa Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cloning And Mutagenesis Market Competitive Landscape And Company Profiles

• 30.1. Cloning And Mutagenesis Market Competitive Landscape
• 30.2. Cloning And Mutagenesis Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Jena Bioscience GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Transgen Biotech Co Overview, Products and Services, Strategy and Financial Analysis

31. Cloning And Mutagenesis Market Other Major And Innovative Companies

• 31.1. New England Biolabs
• 31.2. Merck KGaA
• 31.3. Promega Corporation
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. Danaher
• 31.6. Genomax Technologies Pte Ltd
• 31.7. GENEWIZ Inc.
• 31.8. abm Inc.
• 31.9. GenScript
• 31.10. EZBioscience
• 31.11. Codex DNA Inc.
• 31.12. Aragen Life Sciences
• 31.13. Bio-Techne
• 31.14. Charles River Laboratories
• 31.15. Integrated DNA Technologies

32. Global Cloning And Mutagenesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cloning And Mutagenesis Market

34. Recent Developments In The Cloning And Mutagenesis Market

35. Cloning And Mutagenesis Market High Potential Countries, Segments and Strategies

• 35.1 Cloning And Mutagenesis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cloning And Mutagenesis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cloning And Mutagenesis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer